HudsonAlpha virtual roundtable to provide community awareness, education to North Alabama’s minority population about COVID-19 impact


February 9, 2021 (Huntsville, Ala.) – The HudsonAlpha Institute for Biotechnology will host a virtual roundtable discussion Feb. 22 at 6pm about COVID-19 prevention, variants and community engagement.

The global pandemic has brought awareness of healthcare disparities among minority populations, who have experienced a higher infection and death rate during the pandemic.

According to the Centers for Disease Control and Prevention (CDC), several social determinants that contribute to minority health outcomes include: health access and quality, education access and quality, social and community context, and economic stability.

The event is part one of a two-part Virtual Community Awareness Roundtable series, “A Path Forward.”

“Combating this deadly virus will require community and faith-based organizations, employers, healthcare systems and providers, public health agencies, and policymakers coming together to educate the public and help separate fact from fear,” said Darrell Ezell, PhD, director of diversity, equity and inclusion at HudsonAlpha. “A Path Forward is another step in our mission to connect with the diverse community we live in and provide clear, trusted information informed by science.”

Attendees will hear HudsonAlpha researchers, educators and area leaders discuss:

-Understanding COVID-19 (Exposure and Testing, Variants, Prevention
& Treatment)
-Measures to Promote Health Literacy
-Q&A: Fostering Community Confidence

Part two of “A Path Forward” will take place March 9 and discuss the COVID-19 vaccine, mistrust and mobilization.

Events are free and open to the public. Register for the Feb. 22 roundtable at https://buff.ly/3cHtNug.

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and fosters more than 40 diverse biotech companies on campus. To learn more about HudsonAlpha, visit hudsonalpha.org.